Edesa Biotech, Inc.
EDSA
$7.69
$0.699.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.87% | -27.37% | -10.00% | 1.66% | -68.10% |
| Total Depreciation and Amortization | -1.54% | 0.39% | 5.31% | -43.16% | -2.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.11% | 127.96% | 165.97% | -17.86% | -13.53% |
| Change in Net Operating Assets | -443.71% | 149.90% | 82.52% | -3,552.89% | 83.09% |
| Cash from Operations | -21.28% | -1.19% | 28.64% | -57.09% | -56.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,486.30% | -- | -100.00% | 996.11% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | 441.28% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -318.82% | -- | 100.00% | -355.73% | -205.73% |
| Cash from Financing | 1,699.14% | -- | -100.00% | 613.15% | 6,697.13% |
| Foreign Exchange rate Adjustments | 75.71% | -121.11% | 393.97% | -100.00% | -452.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 180.25% | -2.25% | -112.45% | 2,243.80% | 152.43% |